TGFB1 and rheumatoid arthritis: Early IHC reactivity in patients with RA and PsA who received biologics was higher for DKK1, IL-17, and TGF-β1 levels (Figure 2), and then the study of the area under the curve was carried out considering these values with statistically significant differences.